IGM Biosciences Management
Management criteria checks 2/4
IGM Biosciences' CEO is Mary Harler, appointed in Oct 2024, has a tenure of less than a year. directly owns 0.59% of the company’s shares, worth $3.10M. The average tenure of the management team and the board of directors is 3 years and 6 years respectively.
Key information
Mary Harler
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | 0.6% |
Management average tenure | 3yrs |
Board average tenure | 6yrs |
Recent management updates
Recent updates
We're Not Very Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate
Oct 08IGM Biosciences: Waiting For Godot
Sep 18IGM Biosciences: Unlikely To Move The Needle Again In 2024
May 12Is IGM Biosciences (NASDAQ:IGMS) In A Good Position To Invest In Growth?
Apr 28IGM Biosciences: Imvotamab Data 2nd Half Of 2024 With Other Inflection Points
Feb 12We Think IGM Biosciences (NASDAQ:IGMS) Needs To Drive Business Growth Carefully
Nov 20We're Not Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn
May 10Here's Why We're Not At All Concerned With IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation
Jan 05IGM Biosciences (NASDAQ:IGMS) Is In A Strong Position To Grow Its Business
Sep 23IGM Biosciences started at BofA Securities with a buy on IgM antibody candidates
Aug 29IGM Biosciences GAAP EPS of -$1.33 misses by $0.93, revenue of $0.4M
Aug 08We're Keeping An Eye On IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate
Jun 09IGM Biosciences: Interesting Science, Poor Trial Data
Feb 23Is IGM Biosciences (NASDAQ:IGMS) In A Good Position To Deliver On Growth Plans?
Feb 17Here's Why We're Not Too Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation
Sep 07IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans
May 25CEO
Mary Harler (59 yo)
less than a year
Tenure
Ms. Mary Beth Harler, M.D. is the Chief Executive Officer of IGM Biosciences, Inc. since October 01, 2024 and serves as its Director. She had been Head of Research & Autoimmunity at IGM Biosciences, Inc. s...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | less than a year | no data | 0.59% $ 3.1m | |
Chief Financial Officer | 5.8yrs | US$1.08m | 0.035% $ 186.3k | |
Senior Vice President of Group Operations | 1.8yrs | no data | no data | |
Senior VP | 2.7yrs | no data | 0.0043% $ 22.9k | |
Senior Vice President of Legal Affairs | 3.8yrs | no data | no data | |
Chief Human Resources Officer | 5.4yrs | no data | no data | |
Executive Vice President of Research | 3.3yrs | no data | no data | |
Chief Business Officer | 3.7yrs | US$4.92m | 0.030% $ 160.1k | |
Executive Vice President of Process Development & Manufacturing | 3.6yrs | no data | no data | |
Senior Vice President of Intellectual Property | 2.6yrs | no data | no data | |
Senior Vice President of Quality | 1.8yrs | no data | no data | |
Senior Vice President of Manufacturing Operations | 1.3yrs | no data | no data |
3.0yrs
Average Tenure
55yo
Average Age
Experienced Management: IGMS's management team is considered experienced (3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | no data | no data | 0.59% $ 3.1m | |
Independent Director | 3.8yrs | US$168.55k | 0.0037% $ 19.7k | |
Independent Director | 5.8yrs | US$178.30k | 0.68% $ 3.6m | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 5.3yrs | US$166.09k | 0.016% $ 82.9k | |
Independent Director | 6.3yrs | US$166.09k | 0.15% $ 785.2k | |
Independent Director | 6.3yrs | US$204.09k | 0.0034% $ 17.8k | |
Independent Director | 6.3yrs | US$175.84k | 0.099% $ 522.6k | |
Independent Director | 6.3yrs | US$236.59k | 0% $ 0 | |
Independent Director | 1.1yrs | US$167.54k | 0.0073% $ 38.7k | |
Member of Scientific Advisory Board | no data | no data | no data |
6.0yrs
Average Tenure
55yo
Average Age
Experienced Board: IGMS's board of directors are considered experienced (6 years average tenure).